Related Experiment Videos
Oleoyl-estrone does not have direct estrogenic effects on rats
C Cabot1, M M Grasa, R M Massanés
1Centre Especial de Recerca en Nutrició i Ciència dels Aliments, Facultat de Biologia, Universitat de Barcelona, Spain.
Life Sciences
|August 7, 2001
Summary
Oleoyl-estrone (OE) given intravenously shows estrogenic effects by increasing estrogen levels and tissue growth. However, oral OE does not cause these estrogenic side effects, making it potentially safe as a slimming drug.
Area of Science:
- Endocrinology
- Pharmacology
- Reproductive Biology
Background:
- Oleoyl-estrone (OE) is investigated for potential slimming drug applications.
- Understanding its estrogenic effects is crucial for safety assessment.
Purpose of the Study:
- To evaluate the estrogenic effects of oleoyl-estrone (OE) administration via intravenous (i.v.) and oral routes.
- To determine if oral OE poses estrogenic risks when used as a slimming agent.
Main Methods:
- Comparing estrogenic effects of OE administered via continuous i.v. infusion versus daily oral gavage in rats.
- Measuring plasma levels of estrone (E1) and 17beta-estradiol (E2).
- Assessing uterine and ovarian weight, and mammary gland proliferation.
Main Results:
- Intravenous OE increased E1 and E2 plasma levels, leading to uterine and mammary gland growth.
- Oral OE did not significantly alter E1 or E2 levels or induce estrogenic effects, even at higher doses.
- OE binding to alpha receptors was negligible; estrone binding was a fraction of estradiol binding.
Conclusions:
- Intravenous OE exhibits estrogenic activity primarily due to conversion to estrone and then estradiol.
- Oral administration of OE does not result in significant estrogenic side effects.
- OE appears safe for oral use as a slimming drug regarding estrogenic activity.